European options and recommendations for cancer ... - OECI
PDF) Hepatic carcinosarcoma: an interdisciplinary challenge (Abstract 101)
PDF) Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action
PDF) Scientific contributions of the first female chemists at the University of Vienna mirrored in publications in Chemical Monthly 1902–1919
Cancer Therapy Volume 2 Issue A by Cancer Therapy - Issuu
IJMS | Free Full-Text | Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions | HTML
IJMS | Free Full-Text | Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions | HTML
Pharmaceuticals | Free Full-Text | Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action | HTML
PDF) Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
Volume 10 Edition 2 2013 - The ASIA Miner
PDF) Genexpressionsanalyse primär resezierter Dünndarmkarzinome: Zusammenhang zwischen Prostaglandinsynthasen (COX-1, COX-2, mPGES), TGF-β β1 und Angiogenese (VEGF-A und C) (Abstract 69).
PDF) Predicting Early Failure after Adjuvant Chemotherapy in High-Risk Breast Cancer Patients with Extensive Lymph Node Involvement
Thyroid Cancer - E-Lib FK UWKS
Depeche Mode/Diskografie – Wikipedia
Cell–Cell Contacts in Melanoma and the Tumor Microenvironment | SpringerLink
PDF) Abstract 46: Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
46th Annual Meeting of the Austrian Society of Surgery - PDF Free Download
Pharmaceuticals | Free Full-Text | Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action | HTML
Connective tissue growth factor reacts as an IL - World Journal of ...
Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. - Abstract - Europe PMC
PDF) Lymphatic vessel invasion in upper GI cancer: an indication for an additive or adjuvant therapy? (P21)
Depeche Mode Tickets – Karten bei Eventim
PDF) Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
